Approval · Notice of Compliance 8081 · 2006
VIVAGLOBIN: Notice of Compliance 8081
Issued June 22, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8081
- Date
- June 22, 2006
- Company
- Zlb Behring Canada, Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIVAGLOBIN | 02282518 | Cancelled Post Market |
Medicinal ingredients
- IMMUNOGLOBULIN (HUMAN) 160 MG per ML